Luyan PharmaLtd 대차 대조표 상태
재무 상태 기준 확인 4/6
Luyan PharmaLtd has a total shareholder equity of CN¥3.1B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 161.7%. Its total assets and total liabilities are CN¥12.4B and CN¥9.3B respectively. Luyan PharmaLtd's EBIT is CN¥705.6M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥481.5M.
주요 정보
161.7%
부채 비율
CN¥5.01b
부채
| 이자 보상 비율 | 3.2x |
| 현금 | CN¥481.54m |
| 주식 | CN¥3.10b |
| 총 부채 | CN¥9.30b |
| 총 자산 | CN¥12.40b |
최근 재무 상태 업데이트
업데이트 없음
재무 상태 분석
단기부채: 002788's short term assets (CN¥9.7B) exceed its short term liabilities (CN¥8.4B).
장기 부채: 002788's short term assets (CN¥9.7B) exceed its long term liabilities (CN¥868.5M).
부채 대 자본 내역 및 분석
부채 수준: 002788's net debt to equity ratio (146.1%) is considered high.
부채 감소: 002788's debt to equity ratio has reduced from 176.7% to 161.7% over the past 5 years.
부채 범위: 002788's debt is not well covered by operating cash flow (17.3%).
이자 보장: 002788's interest payments on its debt are well covered by EBIT (3.2x coverage).